These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10353637)

  • 1. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Ru Y; Yamashita DS; Oh HJ; Yen J; Thompson SK; Carr TJ; Levy MA; Tomaszek TA; Ijames CF; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; D'Alessio KJ; McQueney MS; Veber DF
    Bioorg Med Chem; 1999 Apr; 7(4):581-8. PubMed ID: 10353637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic cyanamide-based inhibitors of cathepsin K.
    Barrett DG; Deaton DN; Hassell AM; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3039-43. PubMed ID: 15896958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro.
    James IE; Marquis RW; Blake SM; Hwang SM; Gress CJ; Ru Y; Zembryki D; Yamashita DS; McQueney MS; Tomaszek TA; Oh HJ; Gowen M; Veber DF; Lark MW
    J Biol Chem; 2001 Apr; 276(15):11507-11. PubMed ID: 11148212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
    Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
    J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
    Zhou NE; Guo D; Thomas G; Reddy AV; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2003 Jan; 13(1):139-41. PubMed ID: 12467634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
    Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin K and the design of inhibitors of cathepsin K.
    Yamashita DS; Dodds RA
    Curr Pharm Des; 2000 Jan; 6(1):1-24. PubMed ID: 10637370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Yamashita DS; Ru Y; LoCastro SM; Oh HJ; Erhard KF; DesJarlais RL; Head MS; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; Tomaszek TA; Levy MA; Veber DF
    J Med Chem; 1998 Sep; 41(19):3563-7. PubMed ID: 9733481
    [No Abstract]   [Full Text] [Related]  

  • 13. The propeptide of Fasciola hepatica cathepsin L is a potent and selective inhibitor of the mature enzyme.
    Roche L; Tort J; Dalton JP
    Mol Biochem Parasitol; 1999 Jan; 98(2):271-7. PubMed ID: 10080395
    [No Abstract]   [Full Text] [Related]  

  • 14. Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases.
    Lenarcic B; Krishnan G; Borukhovich R; Ruck B; Turk V; Moczydlowski E
    J Biol Chem; 2000 May; 275(20):15572-7. PubMed ID: 10748022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
    Lynas JF; Hawthorne SJ; Walker B
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
    Tavares FX; Deaton DN; Miller AB; Miller LR; Wright LL; Zhou HQ
    J Med Chem; 2004 Oct; 47(21):5049-56. PubMed ID: 15456248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
    Altmann E; Green J; Tintelnot-Blomley M
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1997-2001. PubMed ID: 12781182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The slow-binding inhibition of cathepsin K by its propeptide.
    Billington CJ; Mason P; Magny MC; Mort JS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.
    Yamashita DS; Dong X; Oh HJ; Brook CS; Tomaszek TA; Szewczuk L; Tew DG; Veber DF
    J Comb Chem; 1999; 1(3):207-15. PubMed ID: 10746010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.
    Brömme D; Klaus JL; Okamoto K; Rasnick D; Palmer JT
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):85-9. PubMed ID: 8670136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.